. Author manuscript; available in PMC: 2017 Jan 15.

Published in final edited form as: Clin Cancer Res. 2015 Sep 17;22(2):328–336. doi: 10.1158/1078-0432.CCR-14-0466

Table 1.

Mean (IQR) of cytokines and stimulatory molecules and p values, when comparing complete responders vs non- or partial-responders before treatment.

	Complete Responders [median(IQR)] n = 37	Non-Responders or Partial Responders [median(IQR)] n=30–32	p-value¹
IL6 (pg/mL)	6.3 (4.0 – 32.2)	44.4 (8.2 – 96.1)	0.043
IL10 (% detectable)	41%	72%	0.0148
sCD23 (U/mL)	69.5 (29.8 – 94.0)	39.4 (26.0 – 68.7)	0.228
sCD30 (U/mL)	102 (76.1 – 227)	157 (62.4 – 376)	0.586
CXCL13 (pg/mL)	238 (155 – 395)	617 (252 – 1030)	0.001
IgE (ng/mL)	21.8 (8.2 – 29.2)	40.2 (7.7 – 146)	0.190
sCD27 (U/mL)	800 (559 – 1250)	758 (526 – 1480)	0.966
LDH	305 (164 – 619)	555 (240 – 1370)	0.0442
IPI (% who had IPI score of 0–1)	92%	66%	0.0198